139 related articles for article (PubMed ID: 10674004)
81. Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study.
Lindemalm S; Liliemark J; Larsson BS; Albertioni F
Med Oncol; 1999 Dec; 16(4):239-44. PubMed ID: 10618686
[TBL] [Abstract][Full Text] [Related]
82. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
83. A crucial role for ATR in the regulation of deoxycytidine kinase activity.
Beyaert M; Starczewska E; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2016 Jan; 100():40-50. PubMed ID: 26620371
[TBL] [Abstract][Full Text] [Related]
84. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
85. Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.
Huang M; Wang Y; Gu J; Yang J; Noel K; Mitchell BS; Schramm VL; Graves LM
Leuk Res; 2008 Aug; 32(8):1268-78. PubMed ID: 18279955
[TBL] [Abstract][Full Text] [Related]
86. Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity.
Stegmann AP; Honders WH; Willemze R; Ruiz van Haperen VW; Landegent JE
Blood; 1995 Mar; 85(5):1188-94. PubMed ID: 7532033
[TBL] [Abstract][Full Text] [Related]
87. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
88. Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts.
Ruiz van Haperen VW; Veerman G; Braakhuis BJ; Vermorken JB; Boven E; Leyva A; Peters GJ
Eur J Cancer; 1993; 29A(15):2132-7. PubMed ID: 8297652
[TBL] [Abstract][Full Text] [Related]
89. The sugar ring of the nucleoside is required for productive substrate positioning in the active site of human deoxycytidine kinase (dCK): implications for the development of dCK-activated acyclic guanine analogues.
Hazra S; Konrad M; Lavie A
J Med Chem; 2010 Aug; 53(15):5792-800. PubMed ID: 20684612
[TBL] [Abstract][Full Text] [Related]
90. Cellular metabolism of 5,6-dihydro-5-azacytidine and its incorporation into DNA and RNA of human lymphoid cells CEM/O and CEM/dCk(-).
Avramis VI; Powell WC; Mecum RA
Cancer Chemother Pharmacol; 1989; 24(3):155-60. PubMed ID: 2472227
[TBL] [Abstract][Full Text] [Related]
91. Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.
Lindemalm S; Albertioni F; Liliemark J
Anticancer Drugs; 1997 Jun; 8(5):445-53. PubMed ID: 9215606
[TBL] [Abstract][Full Text] [Related]
92. Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues.
McSorley T; Ort S; Hazra S; Lavie A; Konrad M
FEBS Lett; 2008 Mar; 582(5):720-4. PubMed ID: 18258203
[TBL] [Abstract][Full Text] [Related]
93. Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status.
Carlini F; Ivaldi F; Gualandi F; Boschert U; Centonze D; Matarese G; Salvetti M; Kerlero de Rosbo N; Uccelli A
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):195-205. PubMed ID: 33851318
[TBL] [Abstract][Full Text] [Related]
94. Biological activity of 1-deazapurine nucleosides: role of deoxycytidine kinase?
Bergman AM; Cristalli G; Vittori S; Wang J; Eriksson S; Peters GJ
Nucleosides Nucleotides; 1999; 18(4-5):897-8. PubMed ID: 10432706
[TBL] [Abstract][Full Text] [Related]
95. Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase.
Sabini E; Hazra S; Konrad M; Lavie A
J Med Chem; 2008 Jul; 51(14):4219-25. PubMed ID: 18570408
[TBL] [Abstract][Full Text] [Related]
96. Requirement for deoxycytidine kinase in T and B lymphocyte development.
Toy G; Austin WR; Liao HI; Cheng D; Singh A; Campbell DO; Ishikawa TO; Lehmann LW; Satyamurthy N; Phelps ME; Herschman HR; Czernin J; Witte ON; Radu CG
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5551-6. PubMed ID: 20080663
[TBL] [Abstract][Full Text] [Related]
97. New insights into the synergism of nucleoside analogs with radiotherapy.
Lee MW; Parker WB; Xu B
Radiat Oncol; 2013 Sep; 8():223. PubMed ID: 24066967
[TBL] [Abstract][Full Text] [Related]
98. Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.
Greer S; Han T; Dieguez C; McLean N; Saer R; Reis I; Levi J; Marquez VE
Anticancer Agents Med Chem; 2017; 17(2):250-264. PubMed ID: 27745548
[TBL] [Abstract][Full Text] [Related]
99. Immunomodulatory Effects Associated with Cladribine Treatment.
Fissolo N; Calvo-Barreiro L; Eixarch H; Boschert U; Espejo C; Montalban X; Comabella M
Cells; 2021 Dec; 10(12):. PubMed ID: 34943995
[TBL] [Abstract][Full Text] [Related]
100. Deoxycytidine in human plasma: potential for protecting leukemic cells during chemotherapy.
Cohen JD; Strock DJ; Teik JE; Katz TB; Marcel PD
Cancer Lett; 1997 Jun; 116(2):167-75. PubMed ID: 9215860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
